Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110489794 | 11048979 | 4 | F | 200810 | 20160706 | 20150420 | 20160708 | EXP | US-009507513-1504USA009844 | MERCK | 0.00 | M | Y | 0.00000 | 20160708 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110489794 | 11048979 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | U | 20788 | 1 | MG | FILM-COATED TABLET | QD | |||||
| 110489794 | 11048979 | 2 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, UNKNOWN | 0 | 5 | MG | TABLET | |||||||
| 110489794 | 11048979 | 3 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, UNKNOWN | U | 0 | 5 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110489794 | 11048979 | 1 | Alopecia |
| 110489794 | 11048979 | 2 | Alopecia |
| 110489794 | 11048979 | 3 | Alopecia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110489794 | 11048979 | DS |
| 110489794 | 11048979 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110489794 | 11048979 | Back injury | |
| 110489794 | 11048979 | Brain injury | |
| 110489794 | 11048979 | Depression | |
| 110489794 | 11048979 | Disturbance in attention | |
| 110489794 | 11048979 | Ejaculation disorder | |
| 110489794 | 11048979 | Endocrine disorder | |
| 110489794 | 11048979 | Erectile dysfunction | |
| 110489794 | 11048979 | Fall | |
| 110489794 | 11048979 | Hormone level abnormal | |
| 110489794 | 11048979 | Hypoaesthesia | |
| 110489794 | 11048979 | Loss of libido | |
| 110489794 | 11048979 | Nerve compression | |
| 110489794 | 11048979 | Penile size reduced | |
| 110489794 | 11048979 | Penis injury | |
| 110489794 | 11048979 | Psychological trauma | |
| 110489794 | 11048979 | Semen volume decreased | |
| 110489794 | 11048979 | Sensory loss | |
| 110489794 | 11048979 | Sexual dysfunction | |
| 110489794 | 11048979 | Testicular disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110489794 | 11048979 | 1 | 200808 | 2009 | 0 | |
| 110489794 | 11048979 | 2 | 200612 | 200906 | 0 | |
| 110489794 | 11048979 | 3 | 200911 | 201310 | 0 |